Tea has consistently been shown to inhibit the occurrence of tumors in experimental animals. The evidence for such a beneficial effect in humans, however, is limited. The authors examined the association between non-herbal tea consumption and cancer incidence in a prospective cohort study of 35,369 postmenopausal Iowa women. In this cohort, information on the frequency of tea drinking and other dietary and lifestyle factors was collected by mailed survey in 1986. After 8 years of follow-up, 2,936 incident non-skin cancer cases were ascertained in this cohort through the State Hearth Registry of Iowa. Proportional hazards regressions were used to derive adjusted relative risks and 95% confidence intervals for the association between tea consumption and cancer incidence. After controlling for confounding factors, the authors found that regular tea consumption was related to a slight, but not statistically significant, reduced incidence of all cancers combined. Inverse associations with increasing frequency of tea drinking were seen for cancers of the digestive tract (p for trend, 0.04) and the urinary tract (p for trend, 0.02). For women who reported drinking £=2 cups (474 ml) of tea per day, compared with those who never or occasionally drank tea, the relative risk for digestive tract cancers was 0.68 (95% confidence interval (Cl) 0.47-0.98) and for urinary tract cancers, 0.40 (95% Cl 0.16-0.98). Similar inverse associations were seen for specific digestive and urinary tract cancers, although site-specific analyses were not statistically significant. No appreciable association of tea drinking was found with melanoma, non-Hodgkin's lymphoma, or cancers of the pancreas, lung, breast, uterine corpus, or ovary. This study suggests that tea, one of the most popular beverages consumed worldwide, may protect against some cancers in postmenopausal women. Am J Epidemiol 1996;144:175-82.
The potential tumor-inhibitory effect of tea has been demonstrated in numerous in vivo and in vitro studies (1, 2) . Administration of tea infusion or tea polyphenols to experimental animals has been shown to reduce the occurrence of tumors, including those of the digestive tract, and to regress the growth of experimental tumors (2) . Epidemiologic studies on the relation between tea consumption and cancer risk have been inconsistent (1) (2) (3) (4) (5) (6) (7) (8) . Some early studies reported an elevated risk of esophageal cancer associated with consumption of high-temperature tea (1, 2) . This association, however, may be caused by thermal injury of hot tea on the esophageal mucosa. Both positive and inverse associations with tea have also been reported for other cancers, including those of the oropharynx, stomach, pancreas, colon, rectum, breast, kidney, and bladder (1) (2) (3) (4) (5) (6) (7) (8) . Such inconsistent associations may be explained partially by differences in tea-drinking habits and the types of tea consumed in various study populations or by failure to control for potential confounding factors.
Interest in the potential cancer-inhibiting effect of tea has been heightened recently by a large casecontrol study in China, in which a dose-response relation between green tea consumption and reduced risk of esophageal cancer was observed in both men and women (3) . Most tea consumed in Western societies, however, is black tea; while it is made from the same plant, many of its constituents differ from those in green tea (1, 2) . In addition, most previous epidemiologic investigations on tea and cancer were casecontrol studies (1-7); they were unable to assess the effect of tea on total cancer incidence. In this report, we examined the relation of tea consumption with the incidence of major cancers in the Iowa Women's Health Study, a prospective cohort study of postmenopausal women.
MATERIALS AND METHODS
Details on the methods used in this cohort study have been published elsewhere (9, 10) . Briefly, in January 1986, a questionnaire was sent to 98,826 randomly selected women aged 55-69 years whose names appeared on the 1985 Iowa State driver's license list. A total of 41,837 women (42.3 percent) completed and returned the questionnaire and were followed for cancer incidence and total mortality. With the exception of lung cancer, the incidence rates of other major cancers among cohort members were similar to the rates observed among women who did not respond to the 1986 baseline mailed questionnaire (11) .
The vital status for cohort members was determined through computer linkage of participant identifiers with Iowa death certificates and the National Death Index and through mailed follow-up questionnaires in 1987, 1989, and 1992 . Information on cancer diagnosis was ascertained through the State Health Registry of Iowa, part of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Based on our follow-up surveys, it is estimated that the outmigration rate among cohort members is less than 1 percent annually. Through December 31, 1993, after 8 years of follow-up, 3,567 women had developed at least one new primary cancer.
The self-administered questionnaire used in the 1986 baseline survey included information on demographic characteristics, menstrual and reproductive history, weight, personal habits, usual diet, medication use, and medical conditions. A paper tape measure and written instructions were enclosed for having a friend measure the circumferences of the waist and hip. The waist/hip circumference ratio was calculated (10) . Diet was assessed using a semiquantitative food frequency questionnaire almost identical to that used in the 1984 Nurses' Health Study (9) . Usual intakes of 127 food items were ascertained. Tea consumption was assessed in me food questionnaire by asking study participants to record their usual consumption level of non-herbal tea in one of the following nine categories: never or less than once per month, 1-3 cups per month, 1 cup per week, 2-4 cups per week, 5-6 cups per week, 1 cup per day, 2-3 cups per day, 4-5 cups per day, and 6 cups per day (1 cup = 237 ml). These categories were then combined into four consumption levels for data analysis (never or monthly (0-3 cups per month), weekly (1-6 cups per week), 1 cup per day, and 2 or more cups per day) to ensure stable estimates of cancer risk in relation to tea consumption. Those who reported never or occasionally (monthly) drinking tea were combined into one category, since very low intake of tea (<3 cups per month) is unlikely to confer any beneficial effect (2) .
For the present analyses, we excluded women who reported a history of cancer other than skin cancer at baseline (n = 3,896), those who had missing information on tea consumption level (n = 2,264), and those who were not postmenopausal (n = 569). A total of 261 women met two or more of the exclusion criteria. After the above exclusions, a total of 35,369 cohort members remained for analysis, including 2,936 women who were diagnosed with cancers during the 8-year follow-up period. Additional exclusions were made for analysis of breast cancer (excluding 1,884 women with prior mastectomy), ovarian cancer (8,064 women widi prior bilateral oophorectomy), and cancers of the cervix and uterine corpus (14,350 women with prior hysterectomy).
Relative risks were used to measure the strength of associations between tea consumption and cancer incidence. Proportional hazards regression (Cox model) was used to control for potential confounders and to derive adjusted relative risks and 95 percent confidence intervals (12) . Person-years were accumulated up to the date of cancer diagnosis for cancer cases and to the date of loss to follow-up, death, or December 31,1993, for noncases. All relative risks were adjusted for the following common risk or protective factors shared by most major cancers: age, education, smoking status, pack-years of cigarette smoking, physical activity, all fruit and vegetable intake, waist/hip circumference ratio, and family history of cancer among female relatives (9, (13) (14) (15) (16) (17) (18) . Relative risks were also adjusted for total energy intake to evaluate the potential independent association of tea consumption and to reduce potential variation in tea intake that may arise from over-or underreporting of the overall food consumption level (19) . Additional adjustment for alcohol consumption did not alter the results appreciably. With the exception of age and pack-years of smoking, the strata for adjusting variables included in multiple Cox regression models are specified in table 1. Age and pack-years of smoking were adjusted as continuous variables, given their linear relations with the risks of most major cancers. Additional adjustments were made in the analyses of pancreatic cancer (prior history of diabetes), lymphoma and kidney cancers (prior history of blood transfusion), and cancers of the breast, ovary, and uterine corpus (age at menarche, age at menopause, and age at first pregnancy). These additional adjusting variables were found to be risk factors for the corresponding cancer sites in this study population (13, 16, 17) . A trend test for a dose-response relation across levels of tea consumption was performed by treating an ordinal-score variable (i.e., 1,2, 8.7 * Percentages were calculated after excluding women with missing data and may not add up to 100% in each tow because of rounding.
t Metric equivalent 1 cup -237 ml.
3, and 4) as a continuous variable in proportional hazards regression after adjustment for potential confounders.
RESULTS
The distribution of tea consumption level by common risk factors for major cancers is presented in table 1. Overall, about 41.7 percent of women reported drinking non-herbal tea at least once a week, and 17.3 percent drank tea daily. Only 8.6 percent of women reported drinking 2 or more cups of tea a day. These frequencies did not vary appreciably with age, physical activity level, body fat distribution (measured by waist/hip circumference ratio), or a family history of cancer in female relatives. Current smokers tended to drink tea less frequently than nonsmokers or exsmokers, but further reduction in consumption frequency was not evident with increasing pack-years of smoking. There were clear positive correlations of tea drinking with education level and total fruit and vegetable intake. Coffee consumption was found not to be correlated with tea drinking; the percentages of daily tea drinkers were 18.5 percent, 14.2 percent, and 16.8 percent from the lowest to the highest coffee consumption groups (data not shown in table). Table 2 presents adjusted relative risks for major cancers in relation to the tea consumption level at baseline. There was a statistically significant inverse association between tea consumption and cancers of the digestive tract, including cancers of the upper digestive tract, colon, and rectum {p = 0.04). Women who reported drinking 2 or more cups of tea per day had an incidence rate of these cancers 68 percent of that in those who never or occasionally drank tea. The risk was further reduced among women who drank 4 or more cups of tea per day (relative risk = 0.37, 95 percent confidence interval (CI) 0.14-0.98). This decreased risk among frequent tea drinkers was seen for all specific cancer sites of the digestive tract, with a more pronounced effect for cancers of the upper digestive tract (month, pharynx, esophagus, and stomach). None of the statistical tests for a linear trend in these site-specific analyses, however, was significant. Another notable inverse association with tea consumption was seen for urinary tract cancer, with the incidence 40 percent as high in women who drank 2 or more cups of tea per day. Again, the inverse association was seen for each specific cancer site, although the trend tests for site-specific analyses were not statistically significant. An apparent inverse association was also observed for leukemia with tea intake, but the dose-response relation was not statistically significant, perhaps because of a small number of cases. No appreciable association of tea drinking was found for other major cancers, including melanoma, nonHodgkin's lymphoma, and cancers of the lung, breast, uterine corpus, and ovary. Overall, drinking 2 or more cups of tea a day was related to a 10 percent reduction in incidence of total cancer, but neither the point estimate of the relative risk nor the trend test for linear association was statistically significant. Additional analyses were performed by the year of cancer diagnosis following the baseline survey (0-4 years vs. 5-8 years) to examine the consistency of the observed associations between tea drinking and digestive and urinary tract cancers over the 8-year followup period. Inverse associations with tea drinking were seen for both cancer sites in both the earlier and the later years of follow-up, although the trend tests were no longer statistically significant because of a smaller number of cases (data not shown in table). For example, compared with never or occasionally drinking tea, drinking 2 or more cups of tea a day was associated with relative risks of 0. Table 3 presents the relation of intake levels of regular coffee with cancers of the digestive and urinary tracts and with all sites combined. No apparent association was observed for coffee drinking with these cancer groups, suggesting that our observed teacancer associations may be due to compounds other than caffeine in tea.
DISCUSSION
Although tea has been shown to inhibit cancer occurrence in most animal experiments, the association of tea with human cancers has been less consistent. Previous epidemiologic studies reported negative, null, or even positive associations of tea consumption with a variety of cancers, including cancers of the oropharynx, esophagus, stomach, colorectum, pancreas, breast, bladder, and kidney (1) (2) (3) (4) (5) (6) (7) (8) . Our prospective cohort study among postmenopausal women found that regular tea drinking may protect against some, but not all, cancers. Women who reported drinking 2 or more cups of tea per day had 40-70 percent of the incidence rates of cancers of the digestive and urinary tracts compared with women who never or infrequently drank tea. In contrast, coffee drinking was not found to be related to the risk of these cancers.
Our finding of an inverse association of tea consumption with digestive tract cancers, particularly those of the upper digestive tract, is consistent with previous epidemiologic studies (1) (2) (3) (4) (20) (21) (22) (23) (24) (25) (26) (27) , including a recently published large case-control study of esophageal cancer in China (3) . In that study, a 50 percent reduction in the risk of esophageal cancer among women who drank green tea regularly was reported. Stomach cancer is the cancer site most consistently related to tea intake in epidemiologic studies (1, 2, 4, (20) (21) (22) (23) . The inverse association of tea consumption with this malignancy has been demonstrated in studies conducted in China (20) , Japan (21, 22) , Sweden (4), and Turkey (23) . Studies on the associations of tea with cancers of the oropharynx and colorectum have been less consistent (1, 2, (24) (25) (26) (27) ). An early cohort study in the United Kingdom reported reduced risks of both colon and rectal cancers with heavy tea consumption, but a dose-response relation was not evident (24) . An inverse association was also suggested for adenomatous polyps of the sigmoid colon in a Japanese case-control study (25) . In contrast, a cohort study among Japanese men in Hawaii found that the daily intake of black tea was associated with a statistically significant increased risk of rectal cancer. The relative risks in that study, however, were adjusted only for age and alcohol intake (28) . A substantially reduced risk of cancer of the nasopharynx but not other pharyngeal cancers was linked to tea drinking in an early case-control study (27) . Recently, Franceschi et al. (26) in an Italian study found that tea • Basic multiple regression model in which all relative risks were adjusted for age, education, smoking status, pack-years of smoking, physical activity, all fruit and vegetable intake, total energy intake, waist/hip ratio, and (amity history of cancer, t Additionally adjusted for prior history of Wood transfusion, i Excluding women with baseline mastectomy, hysterectomy, and oophorectomy. § Metric equivalent 1 cup = 237 ml.
drinking may protect against oral cancers. In another Italian case-control study, tea was found to be inversely related to the risk of oral and pharyngeal cancer but not to cancers of the other digestive tract organs (29) . No inverse association of tea was found for digestive tract cancers in several previous investigations (1, 2) , including a few recently completed studies (5, 6, 30) . Some early studies even reported an increased risk of digestive tract cancers (particularly esophageal cancer) associated with tea consumption (1, 2) . The positive association with esophageal cancer, however, may be largely attributed to thermal injury of hot tea to the mucosa of the upper digestive tract rather than the chemicals in tea per se, since only hot tea, not normal-temperature tea, has been found to be associated with an elevated risk of esophageal cancer (1-3).
There have been many studies that investigated the relation between tea consumption and urinary tract cancer over the past two decades (1, 2) . With a few exceptions, most of these studies reported no association between tea drinking and cancer risk. In a cohort study among British men, Kinlen et al. (24) found a statistically significant positive association of tea with kidney cancer but not with cancer of the bladder. Positive associations for bladder cancer (31) and renal cell carcinoma (32) were also reported in two early case-control studies, but trends in risk were inconsistent. In contrast, Yu et al. (33) reported a significantly reduced risk of renal cell carcinoma among women who drank tea daily. Inverse associations with bladder cancer were also reported from several recent studies, although none of the dose-response relations was statistically significant (34) (35) (36) (37) . In agreement with these more recent studies, our results showed that regular tea consumption was related to a significantly reduced risk of urinary tract cancers in a dose-response manner.
Tea intake has also been inversely linked with some other cancers. Of note is cancer of the pancreas, for which both positive and negative associations were reported in some earlier studies (1, 2) . Two recent investigations, however, found that tea drinking may protect against this fatal malignancy (7, 8) . In addition, inverse associations of tea drinking with cancers of the breast and ovary have also been reported (1,2, 38), but results from previous studies have been very inconsistent. We did not find appreciable associations of tea with these common cancers among postmenopausal women in this cohort study.
The inverse association of tea drinking and digestive tract cancers in the present study may be explained in part by an anticancer effect on the digestive tract via direct contact. This association is also supported by the inhibitory effects of tea on the endogenous formation of N-nitroso compounds (2), potential carcinogens particularly for upper digestive tract cancers, and the formation of heterocyclic aromatic amines (39), potential carcinogens for cancer of the large bowel. Regarding urinary tract cancers, some anticancer tea constituents may exist in urine and act directly on the renal and transitional cells during the secretion and storage process of urine. It has been shown recently that (-)-epigallocatechin and (-)-epicatechin, two major tea polyphenols, can be detected in urine among volunteers who ingest tea preparations (40) .
Differences in the types of tea consumed and tea drinking habits in various study populations are likely to have contributed to inconsistencies in the relation between tea and cancer across previous studies. In some populations, tea drinking is positively correlated with cigarette smoking and alcohol drinking (3, 21, 22) . Residual confounding effects of these factors could favor a positive association between tea and cancer. In addition, it has been shown from experimental studies that tea may counteract the adverse effect of some, but not all, carcinogens and that the tumor-inhibitory effect of tea may depend on its intake level (1, 2). For example, at high concentrations, tea can effectively block endogenous formation of Nnitroso compounds, while at low levels it may facilitate nitrosation reactions (2) . Therefore, differences in exposure levels of both tea and various cancer etiologic factors in various study populations may result in apparently contradictory findings in epidemiologic studies.
Some limitations of this study need to be considered when interpreting the study results. Although tea drinking, like many other personal habits, is likely to be recalled with reasonable accuracy, misclassification of exposure to tea may still exist. The impact of misclassification errors is likely to be compounded with longer follow-up, since no additional assessment of tea consumption was made during the follow-up period, and some cohort members may have changed their tea-drinking habits during this time period. These random errors likely attenuate the true association between tea consumption and cancer incidence. On the other hand, some statistically significant findings could be due to chance alone, given the multiple comparisons made in this paper. Although there are some rationales for analyzing the relations of tea consumption with the combined cancer groups of all digestive tract organs or all urinary tract organs, the etiologic factors for some specific cancer sites in each cancer group are somewhat different. These two cancer groups were formed, however, on the basis of not only the consistency of the inverse association for each Tea Consumption and Cancer Incidence 181 cancer site but also the possible anticancer effect of tea via direct contact. Another limitation of this study is the small number of women (only 8.6 percent of the total cohort) who reported drinking tea regularly (2 or more cups per day); this not only resulted in an unstable estimate of the relative risks of cancer for this heavy tea-drinking group but also precluded detailed analyses of the tea-cancer associations for certain cancer sites. In addition, regular tea drinkers may be at a low risk of developing cancer because of reasons other than tea drinking. The inverse tea-cancer association, however, persisted after careful adjustment for all measured confounders. Furthermore, the specific inverse associations with digestive and urinary tract cancers, the biologic plausibility of these associations, and the observed dose-response relations for urinary tract cancers also indicate that the observed associations are unlikely due to chance alone.
In summary, this prospective cohort study among postmenopausal women suggests that regular tea consumption may protect against cancers of digestive and urinary tract organs. These associations are supported by the potential tumor-inhibitory effects of tea and tea polyphenols seen in most animal studies and by similar findings in some previous epidemiologic studies. Further studies are warranted to assess whether our observed associations are etiologically meaningful.
